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Felix Rosenow,53,54 Mariasavina Severino,55 Benjamin Sinclair,42,50
Hamid Soltanian-Zadeh,56,57 Pasquale Striano,58,59 Peter N. Taylor,60
Rhys H. Thomas,61,62 Domenico Tortora,56 Dennis Velakoulis,63,64 Annamaria Vezzani,65
Lucy Vivash,41,42 Felix von Podewils,66 Sjoerd B. Vos,67,68 Bernd Weber,69
Gavin P. Winston,68,70,71 Clarissa L. Yasuda,8 Alyssa H. Zhu,72 Paul M. Thompson,72
Christopher D. Whelan,6,73 Neda Jahanshad,72 Sanjay M. Sisodiya71,74 and
Carrie R. McDonald75

The epilepsies are commonly accompanied by widespread abnormalities in cerebral white matter. ENIGMA-Epilepsy is a large
quantitative brain imaging consortium, aggregating data to investigate patterns of neuroimaging abnormalities in common epilepsy syndromes, including temporal lobe epilepsy, extratemporal epilepsy, and genetic generalized epilepsy. Our goal was to
rank the most robust white matter microstructural differences across and within syndromes in a multicentre sample of adult epilepsy patients. Diffusion-weighted MRI data were analysed from 1069 healthy controls and 1249 patients: temporal lobe epilepsy with hippocampal sclerosis (n = 599), temporal lobe epilepsy with normal MRI (n = 275), genetic generalized epilepsy
(n = 182) and non-lesional extratemporal epilepsy (n = 193). A harmonized protocol using tract-based spatial statistics was used
to derive skeletonized maps of fractional anisotropy and mean diffusivity for each participant, and ﬁbre tracts were segmented
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using a diffusion MRI atlas. Data were harmonized to correct for scanner-speciﬁc variations in diffusion measures using a batcheffect correction tool (ComBat). Analyses of covariance, adjusting for age and sex, examined differences between each epilepsy
syndrome and controls for each white matter tract (Bonferroni corrected at P 5 0.001). Across ‘all epilepsies’ lower fractional
anisotropy was observed in most ﬁbre tracts with small to medium effect sizes, especially in the corpus callosum, cingulum and
external capsule. There were also less robust increases in mean diffusivity. Syndrome-speciﬁc fractional anisotropy and mean diffusivity differences were most pronounced in patients with hippocampal sclerosis in the ipsilateral parahippocampal cingulum
and external capsule, with smaller effects across most other tracts. Individuals with temporal lobe epilepsy and normal MRI
showed a similar pattern of greater ipsilateral than contralateral abnormalities, but less marked than those in patients with hippocampal sclerosis. Patients with generalized and extratemporal epilepsies had pronounced reductions in fractional anisotropy
in the corpus callosum, corona radiata and external capsule, and increased mean diffusivity of the anterior corona radiata.
Earlier age of seizure onset and longer disease duration were associated with a greater extent of diffusion abnormalities in
patients with hippocampal sclerosis. We demonstrate microstructural abnormalities across major association, commissural, and
projection ﬁbres in a large multicentre study of epilepsy. Overall, patients with epilepsy showed white matter abnormalities in
the corpus callosum, cingulum and external capsule, with differing severity across epilepsy syndromes. These data further deﬁne
the spectrum of white matter abnormalities in common epilepsy syndromes, yielding more detailed insights into pathological
substrates that may explain cognitive and psychiatric co-morbidities and be used to guide biomarker studies of treatment outcomes and/or genetic research.

2456

| BRAIN 2020: 143; 2454–2473

S. N. Hatton et al.

Brain Research Imaging Centre, Cardiff University, Cardiff CF24 4HQ, UK
Institute of Translational Medicine, University of Liverpool, Liverpool L69 3BX, UK
Walton Centre NHS Foundation Trust, Liverpool L9 7LJ, UK
Maryland Psychiatric Research Center, 55 Wade Ave, Baltimore 21228, MD, USA
Department of Neurology and Epileptology, University Hospital Tübingen, Tübingen 72076 BW, Germany
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consortia effort alleviates some of the known sources of
variation and allows for the statistical modelling of other
population differences. Furthermore, pooling raw data
across a large number of centres in a mega-analysis may
offer greater power to detect group effects and enable
cross-syndrome comparisons that have not previously been
possible. [A meta-analysis aggregates summary results (e.g.
effect size estimates, standard errors, and confidence intervals) across studies, but a mega-analysis aggregates individual participant data across studies, and may allow
additional data harmonization. For an empirical comparison between the two techniques using structural MRI data,
refer to Boedhoe et al. (2018).] Further, due to the collation of world-wide harmonized image analysis protocols,
analysis, and reporting of results, white matter differences
in epilepsy can now be directly compared to those of other
neurological and psychiatric disorders, highlighting pathology that may be unique to epilepsy and/or its treatments.
Enhancing NeuroImaging Genetics through Meta-Analysis
(ENIGMA) is a global initiative combining individually collected samples from studies around the world into a single
large-scale study, with coordinated image processing, and
integrating imaging, phenotypic, and genomic data from
hundreds of research centres worldwide (Thompson et al.,
2020). Standardized protocols for image processing, quality
assurance, and statistical analyses were applied using the
validated ENIGMA-diffusion MRI protocols for multisite
diffusion tensor imaging (DTI) harmonization, http://enigma.
usc.edu/ongoing/dti-working-group/ (Jahanshad et al., 2013;
Kochunov et al., 2014, 2015).
Our primary goal was to identify and rank the most robust white matter microstructural alterations across and
within common epilepsy syndromes in a sample of 1249
adult epilepsy patients and 1069 healthy controls across
nine countries from North and South America, Europe
and Australia. First, we studied all patients in aggregate
(‘all epilepsies’) compared to age- and sex-matched controls, followed by targeted analyses focusing on patients
with right and left TLE-HS, right and left non-lesional
TLE (TLE-NL), non-lesional extratemporal epilepsy
(ExE), and GGE. We characterize effect size differences
across and within these epilepsy syndromes in fractional
anisotropy (FA) and mean diffusivity (MD), as well as
axial (AD) and radial (RD) diffusivity. We also examine
regional white matter associations with age of seizure
onset and disease duration.
We hypothesized that, compared to controls, each patient
group would show white matter alterations beyond the suspected epileptogenic region, with unique patterns in each
group. Specifically, we hypothesized that patients with TLE
would show the most pronounced alterations in ipsilateral
temporo-limbic regions, most notably in TLE-HS. We
hypothesized that patients with GGE would show bilateral
fronto-thalamocortical alterations. We also hypothesized
that common white matter alterations would emerge across
the patient groups and that many of these regional alterations would correlate with years of disease duration.
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Epilepsy affects over 50 million individuals worldwide (Bell
et al., 2014). Focal epilepsies account for around 60% of all
adult epilepsy cases, and temporal lobe epilepsy (TLE) is the
most common (Téllez-Zenteno and Hernández-Ronquillo,
2012). TLE is associated with hippocampal sclerosis (HS) in
60–70% of cases (Coan and Cendes, 2013). Among adult
epilepsy patients, up to 20% have genetic generalized epilepsy (GGE), with bilateral synchronous seizure onset and a
presumed genetic background (Scheffer et al., 2017). These
epilepsy syndromes are frequently studied in isolation and
may have distinct pathophysiological substrates and mechanisms. Their unique and shared biological pathways are beginning to be unravelled using population genetics (ILAE,
2018) and transcriptomics (Altmann et al., 2017), paving
the pathway for potential novel treatments.
Once considered primarily ‘grey matter’ diseases, brain
imaging studies with diffusion MRI have helped reveal that
both focal and generalized epilepsies represent network disorders with widespread white matter alterations even in the
absence of visible MRI lesions (Engel et al., 2013). Patients
with TLE, particularly those with HS, may exhibit white
matter abnormalities both proximal to and distant from the
seizure focus, often most pronounced in the ipsilateral hemisphere (Focke et al., 2008; Ahmadi et al., 2009; Labate
et al., 2015; Caligiuri et al., 2016). Studies in patients with
GGE have demonstrated microstructural compromise in
frontal and parietal regions bilaterally, and in thalamocortical pathways (Keller et al., 2011; Lee et al., 2014; Szaflarski
et al., 2016). White matter disruption in epilepsy is also
linked to cognitive functioning (McDonald et al., 2008;
Yogarajah et al., 2008, 2010) and postsurgical seizure outcomes (Bonilha et al., 2015; Keller et al., 2015, 2017;
Gleichgerrcht et al., 2018), indicating the importance of
white matter networks in the pathophysiology and co-morbidities of epilepsy.
Meta-analyses and single-site studies of diffusion MRI
suggest widespread microstructural abnormalities in
patients with focal epilepsy affecting association, commissural, and projection fibres, whereas microstructural differences in GGE are reportedly less pronounced (Otte et al.,
2012; Slinger et al., 2016). Unfortunately, the exact tracts,
spatial pattern, and extent of damage reported varies
across studies, making it hard to draw conclusions about
syndrome-specific and generalized white matter abnormalities in epilepsy. Inconsistencies may be due, in part, to
small sample sizes at individual centres, which may lack
power to detect reliable differences across a large number
of white matter tracts and multiple diffusion measures.
Methods for image acquisition, processing, and tract selection also differ greatly across studies, adding other sources
of variability. Few studies consider white matter abnormalities as a function of sex, age, and key clinical characteristics leading to multiple uncertainties in the findings.
Although meta-analyses reduce some of these limitations,
harmonizing the image processing and data analysis in a
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n/a = not available.

Bonn
CUBRIC
EKUT
EPICZ
EPIGEN_Ireland
Florence
Genova
Greifswald
HFHS_2.6mm
HFHS_3mm
IDIBAPS_31Dir
IDIBAPS_39Dir
IDIBAPS_88Dir
KCL
Liverpool_Walton
Melbourne
MNI
MUSC
NYU
UCL
UCSD
UMG
UNAM
UNICAMP
Combined

Age cases
Mean ± SD
41.8 ± 12.9
28.6 ± 7.7
33.9 ± 13.1
38.3 ± 9.7
35.9 ± 9.0
37.6 ± 13.5
25.3 ± 8.2
34.6 ± 14.0
38.3 ± 13.0
40.1 ± 15.4
39.3 ± 10.1
33.3 ± 9.4
37.6 ± 10.5
35.0 ± 9.5
31.1 ± 10.3
37.2 ± 9.9
32.1 ± 9.5
36.6 ± 10.7
32.6 ± 8.9
38.7 ± 11.4
34.0 ± 11.9
34.1 ± 10.8
31.4 ± 11.7
40.6 ± 9.9
36.1 ± 11.2

Age controls

Mean ± SD

38.0 ± 14.0
28.3 ± 8.4
40.0 ± 14.9
38.6 ± 11.2
34.8 ± 9.5
34.6 ± 11.6
25.3 ± 8.2
n/a
29.5 ± 7.0
n/a
n/a
32.4 ± 6.6
34.1 ± 5.1
30.4 ± 7.5
31.8 ± 7.7
n/a
30.7 ± 7.4
55.2 ± 6.6
30.3 ± 10.0
37.7 ± 12.4
37.3 ± 13.5
36.0 ± 10.4
33.7 ± 12.2
35.5 ± 10.8
35.5 ± 11.7

17.7 ± 11.6
14.7 ± 4.0
19.3 ± 14.2
19.1 ± 12.4
19.1 ± 10.9
14.0 ± 7.4
10.4 ± 4.6
19.2 ± 9.7
19.0 ± 16.9
–
22.5 ± 13.4
16.9 ± 11.8
15.6 ± 11.0
–
14.3 ± 8.8
22.4 ± 12.8
16.4 ± 9.6
18.5 ± 13.5
24.0 ± 12.7
13.9 ± 10.7
19.6 ± 12.9
16.6 ± 8.1
15.8 ± 11.1
12.3 ± 9.6
16.3 ± 11.3

Mean ± SD

Age of onset

23.8 ± 14.2
14.0 ± 9.5
14.6 ± 10.4
19.2 ± 12.5
18.1 ± 12.9
19.0 ± 9.9
14.7 ± 7.7
15.4 ± 9.2
19.0 ± 12.9
–
16.4 ± 11.1
17.6 ± 11.9
22.0 ± 13.3
–
16.7 ± 11.9
14.8 ± 11.2
15.4 ± 10.6
17.8 ± 12.1
8.6 ± 9.9
24.7 ± 14.3
15.2 ± 13.3
15.6 ± 11.7
15.5 ± 12.8
28.3 ± 12.2
19.9 ± 13.0

Duration
of illness
Mean ± SD
44
35
19
113
67
35
20
n/a
21
0
0
30
22
92
40
0
46
58
26
29
47
20
34
271
1069

Total
controls
64
34
15
86
47
4
17
48
57
14
25
19
27
89
33
25
149
43
45
53
55
36
30
234
1249

Total
cases
42
0
0
19
9
0
0
0
6
3
5
3
5
24
5
13
20
19
2
24
17
2
9
92
319

L TLE-HS
cases
22
0
0
26
5
0
1
0
8
3
7
8
10
38
3
5
22
6
2
13
12
5
10
74
280

R TLE-HS
cases
0
0
0
26
17
0
3
0
8
3
3
0
3
0
8
6
23
11
8
6
13
0
9
15
162

L TLE-NL
cases
0
0
0
15
16
2
4
0
7
3
2
1
3
0
5
1
15
7
3
10
13
0
2
4
113

R TLE-NL
cases

ExE
cases
0
0
0
0
0
2
2
13
28
2
7
6
6
0
11
0
69
0
30
0
0
5
0
12
193

GGE
cases
0
34
15
0
0
0
7
35
0
0
1
1
0
27
1
0
0
0
0
0
0
24
0
37
182
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Centre

Table 1 Characteristics of the patient and control samples by site

108
69
34
199
114
39
37
48
78
14
25
49
49
181
73
25
195
101
71
82
102
56
64
505
2318

Total
n

2458
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Table 2 Demographic and clinical characteristics of the total sample
Age (SD)

Sex, % male

Age of onset (SD)

Duration of illness (SD)

1069
1249
319
280
162
113
182
193

35.5 (11.7)
36.1 (11.2)
38.3 (10.6)
39.3 (10.8)
36.1 (10.9)
35.1 (11.4)
31.8 (9.9)
32.7 (11.5)

41.7
42.9
43.3
42.5
38.3
37.2
44.5
43.5

–
16.3 (11.3)
14.5 (11.5)
15.3 (11.6)
18.8 (11.6)
19.5 (12.2)
14.8 (7.3)
17.6 (11.1)

–
19.9 (13.0)
24.2 (13.3)
24.1 (13.9)
17.1 (12.1)
15.1 (11.2)
16.8 (10.5)
15.1 (11.5)

Post hoc comparisons revealed that controls were younger than both TLE-HS groups and older than patients with GGE and ExE (all P-values 5 0.05). Both TLE-HS groups and the
left TLE-NL group were older than the GGE and ExE groups (P 5 0.05). The right TLE-HS group was older than both TLE-NL groups (P 5 0.05).

Materials and methods
All study participants provided written informed consent for the
local study, and the local institutional review boards and ethics
committees approved each included cohort study.

Study sample
This study from the ENIGMA-Epilepsy working group consists
of 21 cohorts from nine different countries and includes diffusion MRI scans from 1069 healthy controls and 1249 adult epilepsy patients. Demographic and clinical characteristics of the
samples are presented in Table 1 (by site) and Table 2 (across
site). An epilepsy specialist assessed seizure and syndrome classifications at each centre, using the International League Against
Epilepsy (ILAE) criteria. For the TLE subgroups, we included
anyone with the typical electroclinical constellation of this syndrome (Berg et al., 2010). All TLE-HS patients had a neuroradiologically-confirmed diagnosis of unilateral hippocampal
atrophy and increased T2 signal on clinical MRI, whereas all
TLE-NL patients had a normal MRI undertaken at the same
time as the analysed diffusion MRI scan. Participants with a
normal MRI and frontal, occipital, or parietal epilepsy were
labelled as ExE. Participants with tonic-clonic, absence or myoclonic seizures with generalized spike-wave discharges on EEG
were included in the GGE group. Data on anti-epilepsy drug
(AED) regimen, seizure frequency, and clinical outcomes (e.g.
drug resistance, postsurgical outcome) were not available at the
time of the analysis. We excluded participants who did not meet
criteria for one of the above epilepsy syndromes or who had
MRI-visible lesions that would disrupt brain morphometry,
including malformations of cortical development, tumours or
prior neurosurgery. Participants were between 18 and 70 years
of age.

Image processing and analysis
Scanner descriptions and acquisition protocols for all sites are
provided in Supplementary Table 1. Individual scanners that
used different acquisition protocols are listed as separate
scanner instances. Each site conducted the preprocessing of
diffusion-weighted images, including eddy current correction,
echo-planar imaging (EPI)-induced distortion correction, and
tensor estimation. Next, diffusion-tensor imaging (DTI)
images were processed using the ENIGMA-DTI protocols.
These image processing and quality control protocols are
freely available at the ENIGMA-DTI (http://enigma.ini.usc.

edu/ongoing/dti-working-group/) and NITRC (https://www.
nitrc.org/projects/enigma_dti/) webpages. Measures of FA,
MD, AD and RD were obtained for 38 regions of interest
(ROIs) using the Johns Hopkins University (JHU) atlas
(Fig. 1).
For analyses of all patients and for each syndrome, we used
the left and right tracts, the midline structures of the body
(BCC), genu (GCC), and splenium (SCC) of the corpus callosum
and the average diffusion metric (FA/MD/AD/RD) across the
whole brain (38 ROIs). Corrections for multiple comparisons
were carried out for each epilepsy syndrome, based on the number of ROIs: 34 bilateral white matter regions + BCC + GCC
+ SCC + Average FA = 38 ROIs: Bonferroni-corrected threshold for significance P = 0.05/38 = 0.001.

Data harmonization
The batch-effect correction tool, ComBat, was used to harmonize between-site and between-protocol variations in diffusion
metrics as previously demonstrated (Fortin et al., 2017). The
method globally rescales the data (all ROIs for FA, MD, RD or
AD separately) for each scanner instance using a z-score transformation map common to all features. ComBat uses an empirical Bayes framework (Johnson et al., 2007) to improve the
variance of the parameter estimates, assuming that all ROIs
share the same common distribution. Thus, all ROIs are used to
inform the statistical properties of the scanner effects. We set
each scanner instance as each individual scanner used in the collection of magnetic resonance exams, and where there were different scanning protocols used on the same scanner, each
protocol was set as a different scanning instance. Scanner type
was used as the batch effect and diagnosis (patients versus controls) and syndrome (GGE, TLE-HS, TLE-NL, and ExE) were
used as the biological phenotypes of interest. This technique has
been recently applied in other ENIGMA DTI investigations of
brain disorders (Villalón-Reina et al., 2019; ZavaliangosPetropulu et al., 2019).

Statistical analysis
Statistical analysis was performed in the Statistical Package for
the Social Sciences (SPSS v26.0). Pearson correlation examined
the association between age of onset and disease duration.
ANOVA was used to test for differences in demographic and
clinical characteristics among the epilepsy syndromes. To test for
differences between syndromes and controls and to test for global effects of age at scan and sex on white matter, multivariate
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Figure 1 Fibre atlas.

analysis of covariance (MANCOVA) was performed per diffusion metric, adjusting for age, age2 and sex. Age2 was included
in all analyses to model the non-linear effects of age on

diffusivity measures (Lebel et al., 2012). ANCOVAs were then
performed of each patient syndrome compared to controls controlling for age, age2 and sex and Bonferroni corrected at

White matter across epilepsy syndromes
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P 5 0.001. Cohen’s d effect sizes were calculated for each right
and left fibre tract between controls and each patient syndrome
based on the estimated marginal means (adjusted for age, age2,
and sex) and interpreted according to the following criteria:
small d = 0.20–0.49; medium d = 0.50–0.79; large d 5 0.80
(Sawilowsky, 2008). Throughout the text and figures, positive effect size values correspond to patients having higher values than
controls, whereas negative effect size values correspond to
patients having lower values relative to controls. Partial correlations controlling for the same covariates were performed to
evaluate the relationship between each fibre tract FA/MD and
age of seizure onset and disease duration (corrected P 5 0.001).
To demonstrate the most robust group differences, only tracts
that showed medium and large effects are described in the text.
Tracts with small effects are detailed in the Supplementary material (see Supplementary Tables 4–7 and Supplementary Figs 1
and 2 for all results). In a follow-up analysis to check that heteroscedasticity was not influencing results, FSL PALM (Winkler
et al., 2014) was used to test if permutation testing of the difference in FA between patients and controls was similar to the core
ANCOVA results (Fig. 3 and Supplementary Table 4). The
model controlled for age and sex and 10 000 permutations were
run with exchangeability blocks (Winkler et al., 2015) set for
permutations to take place within scanner instances only. We
used the Aspin-Welch v test statistic and the simulated significance P(sim) threshold was set at P 5 0.001.

Data availability
The data that support the findings of this study are available on
request from the corresponding author. The data are not all
publicly available in a repository as they contain information
that could compromise the privacy of research participants.

Although there are data sharing restrictions imposed by (i)
ethical review boards of the participating sites, and consent
documents; (ii) national and trans-national data sharing law,
such as GDPR; and (iii) institutional processes, some of which
require a signed MTA for limited and predefined data use, we
welcome sharing data with researchers, requiring only that they
submit an analysis plan for a secondary project to the leading
team of the Working Group (http://enigma.ini.usc.edu). Once
this analysis plan is approved, access to the relevant data will be
provided contingent on data availability and local PI approval
and compliance with all supervening regulations. If applicable,
distribution of analysis protocols to sites will be facilitated.

Results
Demographics
Demographic and clinical characteristics of each sample are
presented in Table 2. A one-way ANOVA with group as the
between-subjects factor revealed differences across the seven
groups in age [F(6,2083) = 13.3, P 5 0.001)]. Two, oneway ANOVAs across the six patient syndromes revealed
group differences in age of seizure onset [F(5,1095) = 6.3,
P 5 0.001] and disease duration [F(5,1039) = 22.4,
P 5 0.001]. Post hoc comparisons revealed that controls
were younger than both TLE-HS groups and older than
patients with GGE and ExE (all P-values 5 0.05). Both
TLE-HS groups and the left TLE-NL group were older than
the GGE and ExE groups (P 5 0.05). The right TLE-HS
group was older than both TLE-NL groups (P 5 0.05). The
GGE and TLE-HS groups had an earlier age of seizure onset

Downloaded from https://academic.oup.com/brain/article/143/8/2454/5894684 by Henry Ford Hospital / Sladen Library user on 11 September 2020

Figure 2 Diffusion MRI harmonization using ComBat. Average FA (top) and MD (bottom) measures across 24 scanners showing differences in mean FA measures per scanner (left) which are harmonized using ComBat (middle). The process corrects the variance in scanner without
altering the biological variance expected with age (right). Red = before correction; Blue = after correction.
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Figure 3 FA effect size bar graphs. ALIC = anterior limb of the internal capsule; CST = corticospinal tract; EC = external capsule; FX.ST =
fornix/stria terminalis; L = left; PCR = posterior corona radiata; PLIC = posterior limb of the internal capsule; PTR = posterior thalamic radiation; R = right; RLIC = rentrolenticular part of the internal capsule; SCR = superior corona radiata; SFO = superior fronto-occipital fasciculus;
SS = sagittal stratum; TAP = tapetum; UNC = uncinate.

White matter across epilepsy syndromes

than the TLE-NL groups. Duration of illness in TLE-HS
groups was longer than in all other groups.

Data harmonization with ComBat

All epilepsies group
Multivariate tests of within-subject effects
Comparing the whole epilepsy group with healthy controls,
significant differences were observed in FA [F(228,13452) =
4.7, P 5 0.001, Pillai’s trace = 0.44, partial g2 = 0.07], MD
[F(228,11688) = 2.8, P 5 0.001, Pillai’s trace = 0.31, partial
g2 = 0.05], RD [F(228,11790) = 3.28, P 5 0.001, Pillai’s
trace = 0.36, partial g2 = 0.06], and AD [F(228,11946) =
1.96, P 5 0.001, Pillai’s trace = 0.22, partial g2 = 0.04].
Sex, age, and age2 all significantly contributed to the model
(Supplementary Table 3). Compared to females, males generally had higher FA, slightly higher RD and no difference in
MD or AD.

All epilepsies versus healthy controls
The ‘all epilepsies’ group showed lower FA than controls
globally in 36 of 38 ROIs (P 5 0.001; Fig. 3 and
Supplementary Table 4), with medium effect size observed
for the average FA (d = –0.71), external capsule (left d = –
0.64, right d = –0.63), body (d = –0.59) and genu (d = –
0.59) of the corpus callosum (BCC and GCC), cingulate
gyrus of the cingulum bundle (CGC, left d = –0.57, right d
= –0.50), sagittal stratum (left d = 0.55, right d = 0.52), anterior corona radiata (ACR, left d = –0.50, right d = –0.52),
and left parahippocampal cingulum (CGH, d = –0.52).
Follow-up permutation testing confirmed that the same
ROIs were significantly lower in FA in patients compared to
controls when accounting for possible heteroscedasticity between scanner instances (Supplementary Table 16).
The ‘all epilepsies’ group showed higher MD than the controls in 27 ROIs (Fig. 4 and Supplementary Table 5). Similar
to the MD, patients showed higher RD in 34 ROIs
(Supplementary Fig. 1 and Supplementary Table 6) with a
medium-sized effect seen in the right external capsule
(d = 0.52). Higher AD was observed in eight ROIs
(Supplementary Fig. 2 and Supplementary Table 7).
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Age of onset and disease duration
Earlier age of seizure onset was significantly correlated (all
P-values 5 0.001) with longer disease duration across all
patients (r = –0.58) and within each syndrome: GGE (r =
–0.39), left TLE-HS (r = –0.65), right TLE-HS (r = –0.66),
left TLE-NL (r = –0.57), right TLE-NL (r = –0.54), and
ExE (r = –0.54).
Across all epilepsy patients, earlier age of onset was associated with lower FA across 28 ROIs (r = 0.1 to 0.3,
P 5 0.001), higher MD in 16 ROIs, and higher RD in 28
ROIs (Supplementary Tables 8, 10 and 12). The most robust
associations were observed between an earlier age of seizure
onset and lower FA in the average FA, GCC, and bilateral
external capsule, and CGC (r’s between 0.16 and 0.19).
There were no significant relationships between age of
onset and AD in the ‘all epilepsies’ group (Supplementary
Table 14).
Across all epilepsy patients, disease duration showed significant
associations
with
diffusivity
measures
(Supplementary Tables 9, 11, 13 and 15). A longer disease
duration was associated with lower FA in 14 ROIs,
increased MD in nine ROIs, and increased RD in 27 ROIs.
Of note, longer disease duration was associated with lower
FA in BCC, CGC, and external capsule, and with lower
Average FA (r’s = –0.15 to –0.17). There were no significant
relationships between disease duration and AD in all
patients.

TLE-HS group
TLE-HS patients versus healthy controls
Left TLE-HS patients (n = 319) showed significantly lower
FA than controls in 35 of 38 ROIs (Fig. 3, Supplementary
Table 4), with large effect size differences in the left external
capsule (d = –1.02), left CGH (d = –1.01), Average FA (d =
–0.92), left CGC (d = –0.89), and left fornix/stria terminalis
(FX/ST, d = –0.83).
Medium-sized effects were observed in GCC (d = –0.79),
left sagittal stratum (d = –0.78), BCC (d = –0.75), right
CGC (d = –0.68), right external capsule (d = –0.68), left superior longitudinal fasciculus (SLF, d = –0.67), left ACR (d
= –0.66), left anterior limb of the internal capsule (ALIC, d
= –0.61), left retrolenticular portion of the internal capsule
(RLIC, d = –0.61), left uncinate (d = –0.61), right SLF (d =
–0.58), left posterior corona radiata (PCR; d = –0.54), right
ACR (d = –0.53), and right sagittal stratum (d = –0.52).
Significantly higher MD was observed in 28 ROIs (Fig. 4
and Supplementary Table 5), with medium-sized effects in
the left external capsule (d = 0.69), left sagittal stratum
(d = 0.66), and average MD (d = 0.55). Left TLE-HS patients
showed significantly higher RD in 33 of 38 ROIs
(Supplementary Fig. 1 and Supplementary Table 6). A large
effect of higher RD was observed for the left external capsule (d = 0.83), and medium-sized effects were seen for the
left sagittal stratum (d = 0.79), left CGC (d = 0.69), left
CGH (d = 0.67), average RD (d = 0.66), right external capsule (d = 0.61), left FX/ST (d = 0.59), left ACR (d = 0.57),
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Initial frequency plots revealed high variability in the distribution of diffusivity measures (e.g. mean FA, mean MD)
among scanner instances (Fig. 2A). After batch correction
with ComBat, the distributions were centred around a common mean (Fig. 2B), but maintained their expected association with age (Fig. 2C). Following this process, extreme
ROI outliers beyond 3 standard deviations (SD) were
removed from the subsequent analysis (i.e. per ROI for a
given subject, not per subject). This approach resulted in the
removal of only one to five ROIs per site, per diffusion parameter. The harmonization process successfully reduced the
variance of diffusivity measures, especially in MD, AD and
RD (Supplementary Table 2).
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Figure 4 MD effect size bar graphs. ALIC = anterior limb of the internal capsule; CST = corticospinal tract; EC = external capsule; FX.ST
= fornix/stria terminalis; L = left; PCR = posterior corona radiata; PLIC = posterior limb of the internal capsule; PTR = posterior thalamic radiation; R = right; RLIC = rentrolenticular part of the internal capsule; SCR = superior corona radiata; SFO = superior fronto-occipital fasciculus;
SS = sagittal stratum; TAP = tapetum; UNC = uncinate.

White matter across epilepsy syndromes

Age of onset and disease duration
For left TLE-HS, earlier age of onset was associated with
lower FA in four ROIs, including the average FA, BCC,
GCC, and left external capsule. Earlier age of seizure onset
was associated with higher RD in two ROIs (Supplementary
Tables 8 and 12). There was no detected relationship between age of onset and either MD or AD in the left TLE-HS
group (Supplementary Tables 10 and 14).
For right TLE-HS, earlier age of onset was related to
lower FA across nine ROIs, including the average FA, BCC,
SCC, right external capsule, left and right CGH, right PCR,
and right SLF, increased MD in seven ROIs, and increased
RD in seven ROIs (Supplementary Tables 8, 10 and 12).
There was no detected relationship between age of onset
and AD in the TLE-HS groups (Supplementary Table 14).
For left TLE-HS patients, longer disease duration was
associated with lower FA in four ROIs (BCC, bilateral
CGC, and left external capsule) and higher RD in one ROI
(left sagittal stratum). There were no significant relationships
between disease duration and MD or AD (Supplementary
Tables 9, 11, 13 and 15). For right TLE-HS, longer disease
duration was associated with lower FA in eight ROIs (average FA and SCC, bilateral tapetum, and right CGH, external
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capsule, PCR, and uncinate), higher MD in six ROIs, and
higher RD in 10 ROIs.

TLE-NL group
TLE-NL versus healthy controls
The left TLE-NL patients (n = 162) showed lower FA than
controls in 20 ROIs (Fig. 3 and Supplementary Table 4),
higher MD in one ROI (Fig. 4 and Supplementary Table 5),
and higher RD in six ROIs (Supplementary Fig. 1 and
Supplementary Table 6). No significant effects of AD were
detected (Supplementary Fig. 2 and Supplementary Table 7).
Right TLE-NL patients (n = 113) showed significantly
lower FA than controls in 19 ROIs (P 5 0.001; Fig. 3 and
Supplementary Table 4), with medium-sized effects observed
in the right external capsule (d = –0.64), right sagittal stratum (d = –0.60), average FA (d = –0.58), right CGH (d =
–0.55), right CGC (d = –0.51) and right uncinate (d =
–0.50). MD was increased in three ROIs (P 5 0.001, Fig. 4
and Supplementary Table 5), specifically the right external
capsule (d = 0.46), right uncinate (d = 0.42) and right sagittal
stratum (d = 0.42). Significantly higher RD was observed in
four ROIs (Supplementary Fig. 1 and Supplementary Table
6), with a medium-sized effect shown in the right external
capsule (d = 0.50). No significant effects of AD were
detected (Supplementary Fig. 2 and Supplementary Table 7).

Age of onset and disease duration
For left TLE-NL, no diffusivity measure was associated with
earlier age of onset or duration of illness (Supplementary
Tables 8–15).
For right TLE-NL patients, younger age of onset and was
related to lower FA in the right uncinate (r = 0.30,
P 5 0.001), but not MD, AD, or RD (Supplementary Tables
8, 10, 12 and 14). Disease duration was also associated with
decreased FA in the right uncinate (r = –0.37, P 5 0.001),
but not MD, AD, or RD (Supplementary Tables 9, 11, 13
and 15).

GGE group
GGE patients versus healthy controls
GGE patients (n = 113) showed significantly lower FA than
controls in 28 ROIs (P 5 0.001; Fig. 3 and Supplementary
Table 4), with medium-sized effects observed in the GCC
(d = –0.57), left SLF (d = –0.57), left external capsule (d =
–0.55), left RLIC (d = –0.51), right SLF (d = –0.51) and left
PCR (d = –0.50). GGE patients showed higher RD in four
ROIs (P 5 0.001, Supplementary Fig. 1 and Supplementary
Table 6). No significant effects were seen for MD or AD
(Fig. 4, Supplementary Fig. 2 and Supplementary Tables 5
and 7).

Age of onset and disease duration
For GGE patients, there was no significant association between diffusivity measures and either age of onset of epilepsy
or its duration.
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SLF (left d = 0.56, right d = 0.53), right ACR (d = 0.52), and
left RLIC (d = 0.51). Higher AD was observed in five ROIs
(Supplementary Fig. 2 and Supplementary Table 7).
Right TLE-HS patients (n = 280) showed lower FA than
controls in 26 of 38 ROIs (P 5 0.001; Fig. 3 and
Supplementary Table 4), with large effects observed for the
average FA (d = –1.06), right CGH (d = –1.02), right external capsule (d = –0.99), right uncinate (d = –0.90), BCC (d
= –0.87), GCC (d = –0.85) and right sagittal stratum (d =
–0.83). Medium-sized effects were observed in the right
ACR (d = –0.78), right CGC (d = –0.73), left external capsule (d = –0.68), left ACR (d = –0.68), left CGC (d =
–0.68), left tapetum (d = –0.68), right posterior thalamic radiation (d = –0.62), right FX/ST (d = –0.61), right SLF (d =
–0.59), right tapetum (d = –0.59), right ALIC (d = –0.55),
right PCR (d = –0.55), left sagittal stratum (d = –0.55), and
left superior corona radiata (d = –0.53).
Higher MD in the patient group were observed in 23
ROIs (Fig. 4 and Supplementary Table 5), with mediumsized effects shown in the right sagittal stratum (d = 0.67),
right external capsule (d = 0.62), right uncinate (d = 0.62),
average MD (d = 0.60) and right ACR (d = 0.59).
Significantly higher RD in the patient group were observed
in 31 ROIs (Supplementary Fig. 1 and Supplementary Table
6), with a large effect observed for the right external capsule
(d = 0.84), and medium effects seen for the right sagittal stratum (d = 0.76), right uncinate (d = 0.72), average RD
(d = 0.70), right ACR (d = 0.69), left external capsule
(d = 0.63), right SLF (d = 0.62), right CGH (d = 0.61), right
CGC (d = 0.57), BCC (d = 0.56), right FX/ST (d = 0.52), and
left ACR (d = 0.51). Higher AD was observed in six ROIs
(Supplementary Fig. 2 and Supplementary Table 7).
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ExE group
ExE patients versus healthy controls

Age of onset and disease duration
For ExE patients, there were no significant associations between diffusivity measures and either age of onset of epilepsy, or its duration.

Cross-syndrome comparisons
Post hoc comparisons were conducted across the syndromes
in the five ROIs that showed the largest effect size in the ‘all
epilepsies’ analysis, namely average FA/MD, ACR, BCC,
CGC, and external capsule averaged across hemispheres
(Fig. 5). ANCOVAs, adjusting for age, age2, sex, age of seizure onset, and disease duration revealed significant group
differences in average FA [F(5,874) = 3.8, P 5 0.05], as well
as FA of the CGC [F(5,874) = 5.0, P 5 0.05] and external
capsule [F(5,874) = 5.8, P 5 0.05].
There were differences across syndromes for the average
MD [F(5,874) = 5.3, P 5 0.05], ACR [F(5,874) = 3.8,
P 5 0.05], BCC [F(5,874) = 4.9, P 5 0.05], CGC [F(5,874)
= 4.2, P 5 0.05], and the external capsule [F(5,874) = 6.2,
P 5 0.05]. Patients with left and right TLE-HS generally
showed lower FA and higher MD than TLE-NL patients, as
well as lower FA/higher MD than GGEs in CGC and the external capsule. The non-lesional groups (GGE, TLE-NL, and
ExE) did not differ from one another.

Comparisons with other disorders
Given the many common white matter FA differences
observed across epilepsy syndromes, the question arises as to
whether these effects are specific to epilepsy or also seen
with other brain disorders. Figure 6 displays effect size differences observed in the ‘all epilepsies’ group (n = 1249) relative to findings from four other ENIGMA working groups:
schizophrenia (n = 1984; mean age, 36.2; 67% male), 22q11
syndrome (n = 334; mean age, 16.9; 54% male), bipolar disorder (n = 1482; mean age, 39.6; 39.3% male), and major
depressive disorder (n = 921; mean age, 40.7; 39% male).
The magnitude of the effect sizes were typically larger in epilepsy, compared to the other disorders for most white matter
regions. Across the white matter regions, effect sizes in
patients with epilepsy were significantly correlated with

those in patients with bipolar disorder (Spearman’s rho
r = 0.53, P 5 0.05), schizophrenia (r = 0.53, P 5 0.05), and
major depressive disorder (r = 0.44, P 5 0.05).

Approach for multiple comparisons
correction
Regional differences in diffusion parameters between syndromes and healthy controls were expressed as effect size
(Cohen’s d). To identify significant differences we adopted a
Bonferroni correction that adjusted for testing 38 ROIs for
each syndrome (P 5 0.001). However, an even more conservative approach corrects for each of the four diffusion metrics across the seven epilepsy syndromes. Implementing this
very conservative Bonferroni cut-off would result in a threshold of P 5 0.05/(38  7  4) = 4.7  10–5. The combination of the large sample size and the observed medium
to large effect sizes in the study results in most regional differences remaining significant even at the very conservative
P-value threshold. However, in contrasts involving a smaller
number of patients (controls compared to GGE or TLE-NL,
for example) more regions would lose the ‘significant’ label
due to the reduced statistical power. Despite these few
exceptions, the exact P-value cut-off does not alter the main
finding that there were widespread white matter abnormalities across epilepsy syndromes. We report all effect sizes and
P-values in the Supplementary material for researchers interested in examining these results with alternate definitions of
statistical significance.

Discussion
This multisite DTI study in epilepsy compared data from
1249 patients with common epilepsy syndromes to 1069
healthy controls. Data were acquired at 21 sites across
North America, South America, Europe, and Australia and
harmonized using the same post-processing pipeline and
batch effect harmonization tool.
Our results reveal marked white matter alterations across
epilepsy syndromes compared to controls, with varying magnitude of FA reduction and increased MD and RD. Effects
were pronounced in patients with TLE-HS and modest in
GGE. In TLE-HS, the greatest changes were seen ipsilateral
to the seizure focus, implying a local effect. Notably, the
magnitude of the diffusion changes was greater in epilepsy
than that seen in schizophrenia, bipolar disorder and major
depressive disorder. The biological basis of reduced FA is
considered primarily loss of axons and myelin sheaths, with
increased RD and MD reflecting myelin disruption and
increased extracellular space (Arfanakis et al., 2002; Concha
et al., 2009). This raises the critical question of whether
these diffusion abnormalities reflect the underlying pathologies that predispose to epilepsy, or if they are the consequence of epilepsy and are a biomarker of secondary
damage. Since changes were more pronounced in those with
a younger age of onset and longer duration of epilepsy, we
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ExE patients (n = 193) showed significantly lower FA than
controls in 33 ROIs (P 5 0.001; Fig. 1 and Supplementary
Table 4), with medium-sized effects observed for average FA
(d = –0.75), BCC (d = –0.65), GCC (d = –0.64), right ACR
(d = –0.63), bilateral external capsule (left d = –0.60, right
d = –0.58), left ALIC (d = –0.57), left ACR (d = –0.55),
and right sagittal stratum (d = –0.51). Higher MD was
observed in six ROIs (P 5 0.001, Fig. 4 and Supplementary
Table 5) and RD in 22 ROIs (P 5 0.001, Supplementary
Fig. 1 and Supplementary Table 6). No significant effects
were seen in AD (Supplementary Fig. 2 and Supplementary
Table 7).
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for age, age2, sex, age of onset, and disease duration. Error bars reflect 95% confidence intervals. Dotted red lines reflect the means of controls.
For FA, average = 0.585, ACR = 0.481, BCC = 0.690, CGC = 0.627, external capsule (EC) = 0.484. For MD, average = 0.000801, ACR =
0.000741, BCC = 0.000881, CGC = 0.000733, external capsule = 0.000739. Significant differences are indicated with asterisks (*P 5 0.05,
** P 5 0.01, *** P 5 0.001). L = left; R = right.
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Figure 5 Syndromic difference in average FA and MD in five ROIs. Mean FA (left) and MD (right) for each patient syndrome, controlling

2468

| BRAIN 2020: 143; 2454–2473

S. N. Hatton et al.

Downloaded from https://academic.oup.com/brain/article/143/8/2454/5894684 by Henry Ford Hospital / Sladen Library user on 11 September 2020

Figure 6 Comparisons of fractional anisotropy measures across neuropsychiatric disorders. (A) Heat map of FA effect sizes for the
‘all epilepsies’ group compared to those in four other ENIGMA disorders: BP = bipolar disorder; MDD = major depressive disorder; SCZ =
schizophrenia. (B). Radar plot of the four disorders that showed significant correlations across white matter tracts. Positive values reflect patient
group values were on average higher than controls, whereas negative values reflect cases where patient group values were on average lower than
that of controls. ALIC = anterior limb of the internal capsule; CST = corticospinal tract; EC = external capsule; FX.ST = fornix/stria terminalis;
PCR = posterior corona radiata; PLIC = posterior limb of the internal capsule; PTR = posterior thalamic radiation; RLIC = rentrolenticular part
of the internal capsule; SCR = superior corona radiata; SFO = superior fronto-occipital fasciculus; SS = sagittal stratum; TAP = tapetum; UNC
= uncinate.

White matter across epilepsy syndromes

Temporal lobe epilepsy
A recent imaging-based meta-analysis (Slinger et al., 2016)
found that patients with TLE had pronounced and widespread white matter injury relative to other patient syndromes. We found that this pattern was much more robust
and ipsilateral in patients with HS, particularly in hippocampal afferent and efferent tracts, including the CGH, FX/ST,
and uncinate. The proximity of these latter white matter
regions to the epileptogenic zone, with changes being greater
ipsilaterally than contralaterally, implies that these alterations are driven by intrinsic factors specific to the TLE-HS
syndrome rather than long-term effects of AEDs. Contrary
to prior work (Ahmadi et al., 2009; Whelan et al., 2018),
we did not find greater abnormalities in patients with left
TLE relative to right TLE in either the TLE-HS or TLE-NL
groups, nor did we find greater injury in males with TLE
relative to females. Rather, males with TLE-HS and TLE-NL
showed higher global FA values relative to females. This
contrasts with a previous meta-analysis that found males
with focal epilepsy to be more vulnerable to white matter injury relative to females (Slinger et al., 2016). These findings
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do not appear to reflect differences in age, age of seizure
onset, or disease duration, as these characteristics did not
differ between males and females in our TLE cohorts. It has
been reported that compared to age-matched females, males
have greater white matter volume and neuronal number
with fewer neuronal processes (Rabinowicz et al., 1999),
which is hypothesized to represent fewer, thicker and more
organized fibres in males compared to more crossing fibre
tracts in females (Schmithorst et al., 2008). This hypothesis
is supported by the finding that higher FA in males compared to females was also observed in our healthy control
sample.
Patients with TLE-NL showed a very mild pattern of
white matter disruption compared to TLE-HS (Campos
et al., 2015) (Figs 3 and 4). Although this may, in part, reflect the greater likelihood for patients with TLE-NL to have
a milder form of epilepsy, previous studies have shown that
even among drug-resistant TLE, patients with TLE-NL harbour less severe cortical (Bernhardt et al., 2016, 2019) and
white matter (Liu et al., 2012) abnormalities compared to
TLE-HS. White matter disruptions in TLE-NL were notable
in the external capsule and sagittal stratum, both of which
contain long-range association pathways. In particular, the
sagittal stratum contains fibres of the inferior fronto-occipital fasciculus and the inferior longitudinal fasciculus (Goga
et al., 2015). These fibres course through the temporal lobe
lateral to the CGH and FX/ST supporting data suggesting
that TLE-HS and TLE-NL involve different epileptogenic
networks (Zaveri et al., 2001; Mueller et al., 2009).
However, many FA/MD alterations did not differ between
TLE-HS and TLE-NL patients, once age of seizure onset and
disease duration were taken into account (Fig. 5). Thus, the
magnitude of these differences appears to be influenced by
differences in clinical characteristics. This is supported by
the association of an earlier age of seizure onset and longer
disease duration with regional white matter disruption in
TLE-HS, but not in TLE-NL.

Genetic generalized epilepsy
GGE includes several related syndromes, defined electrographically by generalized, bisynchronous, and symmetric
activity with spike-wave or polyspike-wave discharges
(Weir, 1965; Seneviratne et al., 2012). These syndromes
have traditionally been associated with thalamocortical dysfunction, with some studies reporting atrophy in the thalamus (Whelan et al., 2018) or thalamocortical networks
(Bernhardt et al., 2009), and other studies reporting no
structural changes relative to controls (McGill et al., 2014).
Although patients with GGE showed modest alterations
relative to patients with focal epilepsy across most fibres,
these differences were broader than those previously
observed (Slinger et al., 2016) and include commissural
(GCC), projection (ACR) and corticocortical association
pathways (external capsule, SLF). In addition, the magnitude
of these changes in the ACR was similar to those observed
in other epilepsy syndromes after adjusting for clinical and
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hypothesize that the white matter changes represent likely
secondary effects rather than being causal. However, a prospective longitudinal study of individuals from diagnosis onward is needed to answer this question.
Although previous studies have investigated white matter alterations within a specific epilepsy syndrome, our
study is the first to include a diverse aggregation of epilepsy syndromes and address the question of shared brain
alterations across syndromes. This analysis revealed widespread reductions in FA across most association, commissural, and projection fibres bilaterally, with smaller effects
of increased MD. The most robust alterations were
observed in frontocentral regions, including the genu and
body of the CC, ACR, CGC, and external capsule. These
regional changes mirror results from our structural MRI
findings (Whelan et al., 2018), which revealed subcortical
atrophy and neocortical thinning in fronto-central, midline structures, including the thalamus, pallidum, pre- and
postcentral gyri, and superior frontal regions bilaterally.
These regions showed the strongest association with both
age of seizure onset and disease duration. Therefore, white
matter abnormalities in these regions may be a result of
both aberrant developmental [i.e. disruptions of late-myelinating pathways due to seizures (Lee et al., 2013;
Ostrowski et al., 2019)] and degenerative [i.e. demyelination and/or axonal loss due to years of epilepsy, recurrent seizures, exposure to AEDs (Günbey et al., 2011)]
processes. Although lower FA and higher MD have been
interpreted as reflecting a combination of pathological
processes, we observed differences across syndromes to be
driven primarily by higher RD supporting the concept
that disrupted or altered myelin, rather than significant
axonal loss, may underlie these changes (Arfanakis et al.,
2002; Song et al., 2002; Concha et al., 2009).
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Extratemporal epilepsy
The group of patients with non-lesional focal ExE showed
the most marked alterations in the BCC, GCC, ACR, CGC,
and external capsule, and showed a similar pattern to the
GGE group of bilateral fronto-central alterations. As frontal
lobe epilepsy is the second most common type of focal epilepsy (Manford et al., 1992), it is likely that this group
dominated the ExE group, explaining the predominance of
fronto-midline pathology. Unlike the TLE-HS, neither age of
seizure onset nor disease duration were associated with regional white matter compromise. This may be related to the
heterogeneity of this patient group, their later age of seizure
onset and/or the fact that this non-lesional group may represent a ‘mild’ form of ExE.

Summary
In summary, we found shared white matter compromise
across epilepsy syndromes, dominated by regional alterations in bilateral midline, fibre bundles. The question
arises as to whether these shared alterations are specific to
epilepsy or are non-specific effects of a chronic brain disorder. Comparison of our effect size to those of five other
ENIGMA populations revealed that the pattern of microstructural compromise in epilepsy was similar to, but
more robust than, the patterns observed in bipolar disorder, schizophrenia, and major depressive disorder. In
particular, the BCC and GCC were commonly affected
across disorders, suggesting that microstructural compromise could reflect a shared patho-physiological mechanism. However, patients with epilepsy tend to have high
rates of comorbid mood disorder (Kanner, 2006) and
these were not characterized in our epilepsy sample.
Therefore, overlap in white matter changes between our
epilepsy cohort and major neuropsychiatric disorders
could reflect the presence of comorbid psychiatric symptoms in our patients. Increasing evidence suggests that
neuropsychiatric disorders themselves are not separated
by sharp neurobiological boundaries (Baker et al., 2019),
but have overlapping of genetic influences and brain dysfunction (Brainstorm Consortium et al., 2018; Radonjic
et al., 2019). Although genetic overlap between these
neuropsychiatric disorders and epilepsy is low, overlap in
dysfunctional brain networks may be partly due to comorbidities, and warrants further investigation.

Limitations
First, although much effort was taken to apply post-acquisition harmonization, each scanner varied in either its image
acquisition protocol or scanner hardware, or both, which
increased methodological heterogeneity. Conversely, our
results can be considered independent of any specific acquisition scheme, head coil or scanner model. Accordingly, while
the absence of a single, standardized magnetic resonance
protocol incorporates scanner variance into the data, it also
provides breadth that enhances the generalizability of findings. Because some sites had a small sample of patients within a particular syndrome or no control data, we were unable
to adequately implement statistical approaches that could
specifically address site/sample bias. The statistical batch
normalization process ComBat corrected differences between
scanner instances, but may not adequately accommodate the
heterogeneous neuropathology of epilepsy, resulting in a
‘smoothing out’ of differences between syndromes.
A second limitation is the challenge of directly ascribing
lower FA and higher MD to demyelination and/or axonal
injury. Specifically, lower FA can reflect the effects of
crossing fibres, increases in extracellular diffusion (e.g.
inflammation, oedema) or other technical or biological
factors. Therefore, advanced diffusion sequences such as
high angular resolution diffusion imaging and multi-shell
diffusion MRI acquisitions, together with analysis of
quantitative contrasts sensitive to tissue microstructural
features and neuropathological investigations, would help
better unravel the biological underpinnings of our
findings.
The GGE and ExE subgroups represented heterogeneous cohorts, which may have contributed to the weaker
effects noted in these groups relative to TLE-HS.
Although we were underpowered in this study to divide
our GGE and ExE patients into more specific syndromes,
future studies of more targeted syndromes (i.e. juvenile
myoclonic epilepsy) would be beneficial. Similarly, although all patients in our study were diagnosed according
to ILAE guidelines, many patients did not receive intracranial EEG (iEEG). In practice, only a very small proportion
of people with epilepsy ever have iEEG. Therefore, we
cannot rule out the possibility that some patients were
misclassified or had multi-focal seizure onsets that were
not detected. The lack of iEEG and postoperative outcome
data on all participants also made it challenging to further
characterize our ExE patients according to seizure laterality or more specific seizure onset, or to confirm that our
TLE-NL group did not include patients with seizure arising from other locations. Furthermore, the lack of clinical
data prevented us from directly assessing how these diffusional changes were associated with specific AED regimens, comorbid disorders, cognitive performances, or
how they relate to clinical outcomes (i.e. drug resistance
or post-operative seizure outcome). These data are now
being collected across the consortium to better characterize patients and evaluate the clinical utility of identifying
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demographic characteristics (Fig. 5). The ACR is part of the
limbic-thalamo-cortical circuitry and includes thalamic projections from the internal capsule to the cortex, including
prominent connections to the frontal lobe bilaterally (Catani
et al., 2002; Wakana et al., 2004). Thus, degradation of
these projection fibres supports the hypothesis that frontothalamic pathology is present in patients with GGE, including juvenile myoclonic epilepsy (Woermann et al., 1999;
Keller et al., 2011).
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syndrome-specific and shared microstructural injury in
epilepsy.

In the largest DTI mega-analysis of epilepsy, we demonstrate
a pattern of robust white matter alterations within and
across patient syndromes, revealing shared and unique features for each syndrome. These patterns of white matter injury may help to explain cognitive impairments associated
with each syndrome [e.g. the extent of memory impairment
in TLE has been linked to the extent of CGH and uncinate
damage (McDonald et al., 2008)], as well as across syndrome similarities in cognitive profiles [e.g. patients with
TLE and GGE both present with executive dysfunction that
may reflect their shared fronto-central white matter damage;
(Abarrategui et al., 2018; Reyes et al., 2018)]. The extent of
microstructural injury may also help to predict postsurgical
seizure (Bonilha et al., 2015) and cognitive (McDonald
et al., 2014) outcomes, or to inform which patients will respond to AEDs (Park et al., 2020). Finally, cross-syndrome
and cross-disease comparisons could help to inform gene expression studies and provide novel insights into shared psychiatric co-morbidities.
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